Occam placed Carlos Campoy as CFO at CytomX [CTMX] Therapeutics. Campoy comes from Alder BioPharmaceuticals, which was acquired by Lundbeck last year. Campoy’s experience also includes positions at Allergan (NYSE: AGN) and Eli Lilly (NYSE: LLY).